-
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Consensus Recommendation of "Buy" by Analysts
来源: Buzz FX / 23 12月 2024 02:06:12 America/Chicago
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Consensus Recommendation of "Buy" by Analysts Written by MarketBeat December 23, 2024 Share Link copied to clipboard. ARS Pharmaceuticals, Inc. ( NASDAQ:SPRY - Get Free Report ) has earned an av
Read more...